VELCADE (Millennium Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the VELCADE drug offered from Millennium Pharmaceuticals, Inc.. This Proteasome Inhibitor [EPC],Proteasome Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Millennium Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | bortezomib |
SUBSTANCE NAME: | BORTEZOMIB |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Proteasome Inhibitor [EPC],Proteasome Inhibitors [MoA] |
ROUTE: | INTRAVENOUS; SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2003-05-13 |
END MARKETING DATE: | 0000-00-00 |
VELCADE HUMAN PRESCRIPTION DRUG Details:
Item Description | VELCADE from Millennium Pharmaceuticals, Inc. |
LABELER NAME: | Millennium Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 3.5(mg/1) |
START MARKETING DATE: | 2003-05-13 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63020-049_a628369e-5225-47c4-8445-a674ea6fcb68 |
PRODUCT NDC: | 63020-049 |
APPLICATION NUMBER: | NDA021602 |
Other BORTEZOMIB Pharmaceutical Manufacturers / Labelers: